Trial Profile
Phase 2 trial will evaluate Pomaglumetad-methionil
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 29 Nov 2018
Price :
$35
*
At a glance
- Drugs Pomaglumetad methionil (Primary)
- Indications Substance-related disorders
- Focus Therapeutic Use
- 29 Nov 2018 According to a Denovo Biopharma Pipeline (November 2018), this trial is expected to begin in 2019.
- 29 Nov 2018 New trial record